Thats just because they settled the lawsuit.
Although, I guess it does add a degree of uncertainty surrounding competition, although in my opinion, once the company has been dragged through the mud, its going to take a long time to clean its image.
If I were requiring a CPAP machine, I'd be going with the market leader, not one that's had a recent recall.
Orders also have fallen.
I guess we'll get a clearer picture on the impact in the morning.
It'll be interesting to see how RMD.NYSE responds, although google pre market showing slight green.
But can easily go one way or the other very quickly.
I'd say this wont amount to much anyway. You need only look at the 6% share price decline on Thursday 18th April when lillys terzepatide weight loss drugs results came out. Share price dropped to $27.63, If you'd bought you'd be up almost 18% in just over a week.
(20min delay)